News and Announcements
SUDA Investor Road Show Presentation September 2016
- Published September 20, 2016 11:34AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
20th September 2016, ASX Announcement
a leader in oro-mucosal drug delivery, today announces that Mr. Stephen Carter, Managing Director and CEO, and Mr. Nick Woolf, Chief Business Officer, are meeting with investors, brokers and analysts in Brisbane, Sydney and Melbourne from 20-23 September 2016.
Overview
- SUDA (ASX: SUD) is a drug delivery company commercialising low-risk pharmaceuticals
- Extensive proprietary technology, expertise and knowhow in formulating and manufacturing oral sprays
- Multiple patent families covering approx. 300 widely-used drugs formulated into oral sprays
- SUDA’s first-in-class oral sprays have demonstrated meaningful advantages vs. standard-of-care tabletsin multiple clinicalstudies
- Multiple oral sprays for large markets – insomnia, malaria, migraine, erectile dysfunction, chemo-induced nausea
To view the full Presentation, please click on the button below.